Day: December 17, 2025

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cabral Gold Inc. (TSX-V: CBR; OTCQX: CBGZF), a junior resource company, has qualified to trade on the OTCQX® Best Market. Cabral Gold Inc. upgraded to OTCQX from the OTCQB® Venture Market. Cabral Gold Inc. begins trading today on OTCQX under the symbol “CBGZF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating...

Leucipa™, FusionPro™ integration will optimize ESP operations Agreement follows third-quarter award for advanced wireline, perforation technologyHOUSTON and LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Wednesday a major award from Kuwait Oil Company (KOC) to provide advanced artificial lift systems and associated services to enhance production in Kuwait’s oil and gas fields. Under the multi-year agreement, Baker Hughes will supply its portfolio of electrical submersible pumps (ESPs), as well as installation, surveillance and maintenance services. ESP performance will be further optimized through the integration of the FusionPro™ intelligent production drive and Leucipa™ automated field production solution, which will enhance operational...

ROUYN-NORANDA, Quebec, Dec. 17, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to present an update on the November development work at the Sleeping Giant Mine, located in the Eeyou Istchee region of Quebec. HighlightsTonnes milled: 1,346 tonnesMill Head Grade: 7.2 g/t% Recovered: 95.8%Ounces Produced: 298 ouncesOunces Poured: 425 ouncesAbcourt advanced the development of its workplaces and continued hiring in November. Abcourt added a fourth mining front as planned. The lower tonnage in November was caused by development sequence in two of the four workplaces.   It was a question of timing to safely advance the workplaces like advancing ventilation to the next sub-level in one of the workplaces.   During a startup, sequencing has a greater...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications Collaboration supports Sagimet’s fixed-dose combination (FDC) program currently in clinical development Sagimet’s Phase 1 pharmacokinetic (PK) trial of combination of denifanstat and resmetirom is underway with topline data anticipated by the end of 2025 Sagimet anticipates selecting one of the innovative forms of resmetirom licensed from TAPI for combination with denifanstat in a fixed dose combination (FDC) tablet for use in Phase 3SAN MATEO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic...

Design phase contract is with a European specialist in radioactive waste processing and nuclear decommissioning MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today the recent signing of an initial design phase contract with a European organization specializing in radioactive waste processing and nuclear decommissioning. As previously reported in the Outlook section of PyroGenesis’ 2nd quarter earnings report, PyroGenesis was in negotiations with a major European entity for the use of plasma in the destruction of low-level radioactive waste. The contract announced today is for a design phase contract toward...

SAN CARLOS, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that Mick Hitchcock, Ph.D., Interim Chief Executive Officer and Board Member, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 from 5:15 PM to 5:55 PM Pacific Time. Additionally, Biomea’s management team will host one-on-one meetings throughout the conference, which will take place from January 12-15. A live audio webcast of the presentation can be accessed here or by visiting the Investors & Media section of Biomea’s website at https://investors.biomeafusion.com/news-events/events. A replay of the webcast will be available following the live presentation. About Biomea FusionBiomea Fusion is a clinical-stage biopharmaceutical...

JUPITER, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bioindustrial applications, diverse commercial applications, today announced a significant expansion of its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering sustainable bio-based products through precision fermentation and advanced biotechnology tools. This expanded partnership broadens the range of products, platforms, and commercial opportunities the companies will jointly deliver to market. Building on their longstanding relationship, this agreement enables Fermbox Bio to manufacture and commercialize...

Beijing, China, Dec. 17, 2025 (GLOBE NEWSWIRE) — Token Cat Limited (Nasdaq: TC) (the “Company” or “Token Cat”)Today announced that Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (“AZI”), a leading enterprise in China’s automobile sales and aftersales services sector, has reached a preliminary consensus with the Company on a proposed equity investment and business cooperation. Pursuant to the proposed arrangement, AZI plans to subscribe for newly issued shares of Token Cat at a price of US$30 per share, with an intended total investment amount of approximately US$100 million. Under the proposed arrangement, AZI plans to subscribe for newly issued shares of Token Cat  at a price of US$30 per share, with an intended total investment amount of approximately US$100 million. According to the current preliminary framework, the...

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX: WM, OTCQX: WLBMF) (“Wallbridge” or the “Company”) is pleased to announce its 2026 budget and plans for its fully-funded 2026 exploration and related technical studies program at its Fenelon, Martiniere, Grasset and Casault gold projects in northwestern Quebec. The Company plans to drill ~25,000 metres in 2026 across the Martiniere, Fenelon, Casault, and Grasset projects, which represents an increase of approximately 30% of drilling over 2025. “As we close out 2025, I am very optimistic about the year ahead, supported by a strong balance sheet and a clearly defined strategy,” said Brian Penny, CEO of Wallbridge. “Our focus remains on unlocking value from our earlier-stage projects while continuing to advance our flagship Fenelon project toward a future...

Excluding prior year self-insurance adjustments, organic growth, adjusted EPS and adjusted EBITDA exceed management expectationsFourth quarter revenue was a record $2.3 billion, an increase of 5.4% over the prior year, with organic growth of 4.8% contributing meaningfully to overall performance Net income for the quarter totaled $34.8 million, or $0.56 per diluted share, improving from a net loss of $(11.7) million, or $(0.19) per share, a year ago Adjusted diluted EPS was $0.88, which includes a $(0.26) impact from prior year self-insurance adjustments, versus $0.88 last year, which included a $(0.02) impact Adjusted EBITDA for the quarter was $124.2 million, which incorporates a $(22.2) million pre-tax impact from prior year self-insurance adjustments; this compares with $125.6 million last year, which included a $(2.4) million pre-tax...